A group of 146 experts representing 29 organizations and professional societies met
September 18-19, 2006, in Bethesda, MD, to develop revised evidence-based, consensus …

Objective. To provide revised evidence-based consensus guidelines for managing women
with abnormal cervical cancer screening test results. Participants. A group of 146 experts …

New data have emerged since publication of the American Society for Colposcopy and
Cervical Pathology's 2001 consensus guidelines for management of abnormal cervical …

Despite the significant advances in the last decades, low implantation rate per transferred
embryo still remains a major concern in assisted reproductive techniques, highlighting a …

Eine Aktualisierung der in Deutschland für die gynäkologische Zytodiagnostik
gebräuchlichen Münchner Nomenklatur II war wegen neuer Erkenntnisse zur Tumorbiologie …

Glandular abnormalities of the cervix remain a difficult clinical problem. It is a challenge for
the clinician to manage and follow this unusual cytologic finding properly. This article …

Abstract We studied 1,183 Papanicolaou (Pap) cytology cases (739 with normal endometrial
cells [nEMCs], 423 with atypical EMCs [aEMCs], and 21 with endometrial cancer cells …

Background Exfoliated endometrial cells can be seen in cervical smears in association with
a wide variety of conditions ranging from normal proliferative endometrium to endometrial …

Background: Historically the conventional Pap smear has been an effective screening tool
for Carcinoma cervix. However the reporting of benign and malignant endometrial cells on …

Objective The 2001 Bethesda System for Reporting Cervical Cytology includes
documenting'endometrial cells in women≥ 40 years of age '(E40) to help identify …